benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucosal Spray [Orasep Reformulated Dec 2013]

RxCUI: 1485227
RxNorm name: benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucosal Spray [Orasep Reformulated Dec 2013]
Display name: ORASEP REFORMULATED DEC 2013 (Mucosal)
Full name: benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucosal Spray [Orasep Reformulated Dec 2013]
Term type: SBD
Status: Active
Strength: 2-0.1-0.5%
Dose form: Spray
Route: Mucosal
Updated: 2026-08-10 19:20:04

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 012014
Active start: 012014
Multiple ingredient: YES
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
benzocaine	20 MG / 1 ML	benzocaine	benzocaine
cetylpyridinium chloride	1 MG / 1 ML	cetylpyridinium	cetylpyridinium chloride
menthol	5 MG / 1 ML	menthol	menthol

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Mucosal Spray	346163

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
benzocaine	1399
cetylpyridinium	2286
menthol	6750

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	Orasep (benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % ) Mucosal Spray, Reformulated Dec 2013	1	NAMES
RxNorm Name	benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucosal Spray [Orasep Reformulated Dec 2013]	1	NAMES
RxNorm Synonym	Orasep (benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % ) Mucosal Spray, Reformulated Dec 2013	1	NAMES
TTY	SBD	1	ATTRIBUTES
SPL_SET_ID	7c50d986-6a7b-425f-90a0-a60e21283bdf	1	CODES
RxCUI	1485227	1	CODES
MMSL_CODE	BD27957	1	CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDC	Product NDC	Name	Labeler	Application
54859-504-01	54859-504	Orasep Benzocaine, Menthol, Cetylpyridinium Chloride	Llorens Pharmaceutical International Division	M022

Drugs@FDA Applications#

Application, NDC, Name table
Application	NDC	Name	Marketing category	Labeler
M022	54859-504	Orasep Benzocaine, Menthol, Cetylpyridinium Chloride	OTC MONOGRAPH DRUG	Llorens Pharmaceutical International Division

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
54859050401	rxnav_ndcs	yes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
7c50d986-6a7b-425f-90a0-a60e21283bdf	Orasep 2 % / 0.5 % / 0.1 % Mucosal Spray, Reformulated Dec 2013 [PSN] · benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucosal Spray [Orasep Reformulated Dec 2013] [SBD] · Orasep (benzocaine 2 % / menthol 0.5 % / cetylpyridinium chloride 0.1 % ) Mucosal Spray, Reformulated Dec 2013 [SY]	3	7	Llorens- Orasep Spray 504	20251231

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
7c50d986-6a7b-425f-90a0-a60e21283bdf	Llorens- Orasep Spray 504	Llorens Pharmaceutical International Division \| Lex Inc.	20251231
e2edd111-a748-40aa-aee8-d56f0533277d		National Council for Prescription Drug Programs	20120724

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	D04AB	Anesthetics for topical use	ATC1-4		benzocaine
ATC	R02AD	Anesthetics, local	ATC1-4		benzocaine
ATC	B05CA	Antiinfectives	ATC1-4		cetylpyridinium
ATC	R02AA	Antiseptics	ATC1-4		cetylpyridinium
ATC	N01BA	Esters of aminobenzoic acid	ATC1-4		benzocaine
ATC	C05AD	Local anesthetics	ATC1-4		benzocaine
ATC	D09AA	Medicated dressings with antiinfectives	ATC1-4		cetylpyridinium
ATC	D08AJ	Quaternary ammonium compounds	ATC1-4		cetylpyridinium
FDASPL	N0000185508	Standardized Chemical Allergen	EPC	has_epc	benzocaine
FDASPL	N0000184306	Cell-mediated Immunity	PE	has_pe	benzocaine
FDASPL	N0000175629	Increased Histamine Release	PE	has_pe	benzocaine
MEDRT	D001566	Benzocaine	CHEM	has_ingredient	benzocaine
MEDRT	D002594	Cetylpyridinium	CHEM	has_ingredient	cetylpyridinium chloride
MEDRT	D002594	Cetylpyridinium	CHEM	has_ingredient	cetylpyridinium
MEDRT	D008610	Menthol	CHEM	has_ingredient	menthol
MEDRT	D001424	Bacterial Infections	DISEASE	ci_with	benzocaine
MEDRT	D002056	Burns	DISEASE	may_treat	benzocaine
MEDRT	D003773	Dental Plaque	DISEASE	may_prevent	cetylpyridinium chloride
MEDRT	D003773	Dental Plaque	DISEASE	may_prevent	cetylpyridinium
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	menthol
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	benzocaine
MEDRT	D004433	Earache	DISEASE	may_treat	benzocaine
MEDRT	D005401	Fissure in Ano	DISEASE	may_treat	benzocaine
MEDRT	D006484	Hemorrhoids	DISEASE	may_treat	benzocaine
MEDRT	D006561	Herpes Simplex	DISEASE	may_treat	benzocaine
MEDRT	D019226	Oral Ulcer	DISEASE	may_treat	benzocaine
MEDRT	D010032	Otitis Externa	DISEASE	may_treat	benzocaine
MEDRT	D010033	Otitis Media	DISEASE	may_treat	benzocaine
MEDRT	D010146	Pain	DISEASE	may_treat	menthol
MEDRT	D010146	Pain	DISEASE	may_prevent	benzocaine
MEDRT	D011537	Pruritus	DISEASE	may_treat	benzocaine
MEDRT	D012871	Skin Diseases	DISEASE	may_treat	menthol
MEDRT	D014098	Toothache	DISEASE	may_treat	benzocaine
MEDRT	N0000000069	Calcium Channel Antagonists	MOA	has_moa	menthol
MEDRT	N0000000180	Sodium Channel Interactions	MOA	has_moa	benzocaine
MEDRT	N0000008889	Decreased Sensory-Somatic Nervous System Organized Electrical Activity	PE	has_pe	menthol
MEDRT	N0000008889	Decreased Sensory-Somatic Nervous System Organized Electrical Activity	PE	has_pe	benzocaine

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Orasep Reformulated Dec 2013	rxnav_allrelated
DF	DF	Mucosal Spray	rxnav_allrelated
DFG	DFG	Mucosal Product	rxnav_allrelated
IN	IN	benzocaine	rxnav_allrelated
IN	IN	cetylpyridinium	rxnav_allrelated
IN	IN	menthol	rxnav_allrelated
MIN	MIN	benzocaine / cetylpyridinium / menthol	rxnav_allrelated
PIN	PIN	cetylpyridinium chloride	rxnav_allrelated
SBD	SBD	benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucosal Spray [Orasep Reformulated Dec 2013]	rxnav_allrelated
SBDC	SBDC	benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML [Orasep Reformulated Dec 2013]	rxnav_allrelated
SBDF	SBDF	benzocaine / cetylpyridinium / menthol Mucosal Spray [Orasep Reformulated Dec 2013]	rxnav_allrelated
SBDFP	SBDFP	benzocaine / cetylpyridinium chloride / menthol Mucosal Spray [Orasep Reformulated Dec 2013]	rxnav_allrelated
SBDG	SBDG	Orasep Reformulated Dec 2013 Mucosal Product	rxnav_allrelated
SCD	SCD	benzocaine 20 MG/ML / cetylpyridinium chloride 1 MG/ML / menthol 5 MG/ML Mucosal Spray	rxnav_allrelated
SCDC	SCDC	benzocaine 20 MG/ML	rxnav_allrelated
SCDC	SCDC	cetylpyridinium chloride 1 MG/ML	rxnav_allrelated
SCDC	SCDC	menthol 5 MG/ML	rxnav_allrelated
SCDF	SCDF	benzocaine / cetylpyridinium / menthol Mucosal Spray	rxnav_allrelated
SCDFP	SCDFP	benzocaine / cetylpyridinium chloride / menthol Mucosal Spray	rxnav_allrelated
SCDG	SCDG	benzocaine / cetylpyridinium / menthol Mucosal Product	rxnav_allrelated
SCDGP	SCDGP	benzocaine / cetylpyridinium chloride / menthol Mucosal Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	20 MG/ML / 1 MG/ML / 5 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
ATTRIBUTES	SCHEDULE	0
NAMES	Prescribable Synonym	Orasep 2 % / 0.5 % / 0.1 % Mucosal Spray, Reformulated Dec 2013
SOURCES	Source	Metathesaurus FDA Structured Product Labels
SOURCES	Source	Micromedex RED BOOK
SOURCES	Source	Multum MediSource Lexicon